HPLC Column Screening for Favipiravir on Six Different Columns

Abstract:

Favipiravir, a pyrazinecarboxamidederivative, is an antiviral medication discovered by ToyomaChemical (Fujifilm Group) and approved for use in Japan to treat resistant cases of influenza. Currently Favipiravir is also being studied in various clinical trials globally as a potential treatment for COVID-19.

Document Type:

Technical Notes

Industries:

Pharmaceutical/Biopharmaceutical

Techniques:

HPLC / UHPLC

Brands:

Kinetex Luna

PDF Link:

Click here